These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31414547)

  • 1. Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here? Authors' reply.
    Rühlemann M; Franke A
    Aliment Pharmacol Ther; 2019 Sep; 50(5):606-607. PubMed ID: 31414547
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: gut microbial profile associated with primary sclerosing cholangitis-what is new and how do we progress from here?
    Quraishi MN; Shaheen WA
    Aliment Pharmacol Ther; 2019 Sep; 50(5):605-606. PubMed ID: 31414544
    [No Abstract]   [Full Text] [Related]  

  • 3. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls.
    Kummen M; Holm K; Anmarkrud JA; Nygård S; Vesterhus M; Høivik ML; Trøseid M; Marschall HU; Schrumpf E; Moum B; Røsjø H; Aukrust P; Karlsen TH; Hov JR
    Gut; 2017 Apr; 66(4):611-619. PubMed ID: 26887816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
    Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
    World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis.
    Iwasawa K; Suda W; Tsunoda T; Oikawa-Kawamoto M; Umetsu S; Inui A; Fujisawa T; Morita H; Sogo T; Hattori M
    Gut; 2017 Jul; 66(7):1344-1346. PubMed ID: 27670376
    [No Abstract]   [Full Text] [Related]  

  • 6. Manipulation of the Gut-Liver Axis Using Microbiome Restoration Therapy in Primary Sclerosing Cholangitis.
    Bajaj JS; Hays RA
    Am J Gastroenterol; 2019 Jul; 114(7):1027-1029. PubMed ID: 30920413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota in PSC : From association to possible causality. Commentary to "Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis" by Nakamoto et al., Nature Microbiology, January 2019.
    Lemoinne S; Sabino J; Sokol H
    Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):123-125. PubMed ID: 31262571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
    Tan LZ; Reilly CR; Steward-Harrison LC; Balouch F; Muir R; Lewindon PJ
    Gut; 2019 Aug; 68(8):1533-1535. PubMed ID: 30131321
    [No Abstract]   [Full Text] [Related]  

  • 9. The Microbiome and Primary Sclerosing Cholangitis.
    Ali AH; Carey EJ; Lindor KD
    Semin Liver Dis; 2016 Sep; 36(4):340-348. PubMed ID: 27997974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The features of mucosa-associated microbiota in primary sclerosing cholangitis.
    Torres J; Bao X; Goel A; Colombel JF; Pekow J; Jabri B; Williams KM; Castillo A; Odin JA; Meckel K; Fasihuddin F; Peter I; Itzkowitz S; Hu J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):790-801. PubMed ID: 26857969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Intestinal Microbiota in Ulcerative Colitis Patients with and without Primary Sclerosing Cholangitis.
    Kevans D; Tyler AD; Holm K; Jørgensen KK; Vatn MH; Karlsen TH; Kaplan GG; Eksteen B; Gevers D; Hov JR; Silverberg MS
    J Crohns Colitis; 2016 Mar; 10(3):330-7. PubMed ID: 26526357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could gut microbiota protect against sclerosing cholangitis?
    Marschall HU; Bäckhed F
    Hepatology; 2016 Jan; 63(1):26-7. PubMed ID: 26315989
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: gut microbiota profile in patients with autoimmune hepatitis-a clue for adjunctive probiotic therapy? Authors' reply.
    Liwinski T; Schramm C
    Aliment Pharmacol Ther; 2020 Jul; 52(2):394-395. PubMed ID: 32592249
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of gut microbiota in primary biliary cholangitis.
    Jin WM; Song SY; Xu XF; Wen CP; Hu CF
    Hepatobiliary Pancreat Dis Int; 2022 Dec; 21(6):597-599. PubMed ID: 35780017
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.
    Bond A; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1087-1088. PubMed ID: 30920048
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal microbiota in primary sclerosing cholangitis.
    Hov JR; Kummen M
    Curr Opin Gastroenterol; 2017 Mar; 33(2):85-92. PubMed ID: 28030369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: the role of colonic inflammation in the progression of liver disease in primary sclerosing cholangitis-Authors' reply and Letter: the effects of colectomy prior to the diagnosis of primary sclerosing cholangitis on prognosis may have been overestimated.
    Nordenvall C; Bergquist A
    Aliment Pharmacol Ther; 2018 Feb; 47(3):441-442. PubMed ID: 29314129
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?
    Tornai D; Papp M
    Aliment Pharmacol Ther; 2021 Jan; 53(2):350-351. PubMed ID: 33368511
    [No Abstract]   [Full Text] [Related]  

  • 19. Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis.
    Rühlemann MC; Heinsen FA; Zenouzi R; Lieb W; Franke A; Schramm C
    Gut; 2017 Apr; 66(4):753-754. PubMed ID: 27216937
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.
    Sabino J; Vieira-Silva S; Machiels K; Joossens M; Falony G; Ballet V; Ferrante M; Van Assche G; Van der Merwe S; Vermeire S; Raes J
    Gut; 2016 Oct; 65(10):1681-9. PubMed ID: 27207975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.